{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:21:02Z","timestamp":1784132462792,"version":"3.55.0"},"reference-count":131,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2022,4,3]]},"DOI":"10.1080\/09546634.2020.1810607","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T01:26:59Z","timestamp":1597800419000},"page":"1213-1224","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":23,"title":["Onychomycosis in children \u2013 review on treatment and management strategies"],"prefix":"10.1080","volume":"33","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON, Canada"},{"name":"Mediprobe Research Inc., London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maanasa","family":"Venkataraman","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc., London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON, Canada"},{"name":"Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON, Canada"},{"name":"Division of Dermatology, Women\u2019s College Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13677"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12873"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13561"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00349.x"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.104794"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.1998.1998015464.x"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13392"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.12.010"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb00932.x"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)80215-0"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01802.x"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2002.00047.x"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.00182.x"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02513.x"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2010.01878.x"},{"issue":"7","key":"CIT0016","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1468-3083.2006.01631.x","volume":"20","author":"Sigurgeirsson B","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2015-0140"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2005.01186.x"},{"issue":"2","key":"CIT0019","first-page":"105","volume":"16","author":"Eichenfield LF","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12986"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2012.01769.x"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00832.x"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13358"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.0736-8046.2004.21117.x"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417716362"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.062"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.3.415"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-013-9620-9"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05029.x"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02498.x"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1080\/000155502762064764"},{"issue":"7","key":"CIT0032","first-page":"101","volume":"98","author":"Ginter G.","year":"1998","journal-title":"Acta Dermatovenerol Alp Panon Adriat"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(03)00033-0"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.8.1955"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.1004"},{"key":"CIT0036","doi-asserted-by":"crossref","unstructured":"Eichenfield LF, Elewski B, Sugarman J, et\u00a0al. Safety, pharmacokinetics, and efficacy of efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients. 2020 Maui Derm for Dermatologists Annual Meeting; 2020; Grand Wailea, Hawaii, USA.","DOI":"10.36849\/JDD.2020.5401"},{"key":"CIT0037","unstructured":"Jublia (Efinaconazole) Package Insert [Internet]. Bridgewater, NJ, USA; Drugs@FDA; 2014. [Revised 2020]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/203567s000lbl.pdf."},{"issue":"2","key":"CIT0038","first-page":"190","volume":"18","author":"Rich P","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"CIT0039","unstructured":"Kerydin (Tavaborole) Package Insert [Internet]. Drugs@FDA; 2018. Available from https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/204427s006lbl.pdf."},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12064"},{"key":"CIT0041","unstructured":"Penlac (Ciclopirox) Package Insert [Internet]. Drugs@FDA; 2004. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda.docs\/label\/2004\/21022s004lbl.pdf."},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1177\/1203475416677722"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2018.1461834"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(03)00029-9"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(03)00030-5"},{"key":"CIT0047","unstructured":"Novartis. LAMISIL (terbinafine hydrochloride) oral granules, 125\u2009mg or 187.5\u2009mg. [Internet] Drugs@FDA; 2019. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/022071s015lbl.pdf."},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13613"},{"key":"CIT0049","unstructured":"Novartis. LAMISIL (terbinafine hydrochloride) Tablets, 250\u2009mg. [Internet] Drugs@FDA; 2019. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020539s033lbl.pdf."},{"key":"CIT0050","unstructured":"Janssen Pharma. SPORANOX\u00ae (itraconazole) Capsules. [Internet] Drugs@FDA; 2018. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020083s062lbl.pdf."},{"key":"CIT0051","unstructured":"Pfizer. Product monograph Diflucan [Internet] Drugs@FDA; (Revised); 2018. Available from: https:\/\/www.pfizer.ca\/sites\/default\/files\/201806\/Diflucan_PM_E_207077_12June2018.pdf."},{"issue":"2","key":"CIT0052","first-page":"161","volume":"18","author":"Mayser P","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb00900.x"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00691.x"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00819-10"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15088"},{"key":"CIT0057","unstructured":"Pfizer. DIFLUCAN (Fluconazole) Tablets 50\u2009mg, 100\u2009mg, 150\u2009mg and 200\u2009mg. Oral suspensions 350\u2009mg or 1400\u2009mg [Internet]. Drugs@FDA; 2019. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/019949s065,020090s047lbl.pdf."},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03698.x"},{"key":"CIT0059","unstructured":"Janssen Pharma. SPORANOX\u00ae (itraconazole) Oral solution [Internet]. Drugs@FDA; 2012. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020657s027lbl.pdf."},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M165"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.109072"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.109071"},{"key":"CIT0063","unstructured":"Valeant Canada LP. Product monograph Penlac [Internet]; 2012. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00015736.PDF."},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01156.x"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198529040-00002"},{"key":"CIT0066","unstructured":"Loprox (ciclopirox) Nail Lacquer 8% Clinical pharmacology and biopharmaceutical FDA document [Internet]. Drugs@FDA; 2003. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21159_Loprox_biopharmr.pdf."},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1159\/000210929"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.7547\/87507315-90-10-495"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03164.x"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1159\/000488606"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16394"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.18646.1"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00420-9"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549010-00008"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1159\/000247588"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2004.01090.x"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2014.40968"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1016\/0926-9959(94)00075-B"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb00277.x"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb00278.x"},{"key":"CIT0081","unstructured":"Accord. Amorolfine 5%w\/vmedicated nail lacquer package leaflet: information for the user [Internet]. emc; 2019 [cited 2020 May 28]: https:\/\/www.medicines.org.uk\/emc\/files\/pil.3292.pdf."},{"key":"CIT0082","unstructured":"Accord. Amorolfine 5%w\/vmedicated nail lacquer summary of product characteristics [Internet]. emc; 2019. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/3292\/smpc."},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.7547\/16-154"},{"issue":"1","key":"CIT0084","first-page":"55","volume":"13","author":"Gupta AK","year":"2015","journal-title":"Skinmed"},{"key":"CIT0085","first-page":"6185","volume":"9","author":"Jinna S","year":"2015","journal-title":"Drug Des Dev Ther"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2015.51.10.2386986"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2016.1206467"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.14.76"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(01)00989-9"},{"key":"CIT0090","unstructured":"Hold KM, Bu W, Sanders V, et\u00a0al.In vivonail residence time of AN2690, a novel broad-spectrum antifungal agent in development for the topical treatment of onychomycosis; 2007. www.anacor.com\/pdf\/poster_1816.pdf."},{"issue":"7","key":"CIT0091","first-page":"675","volume":"14","author":"Vlahovic T","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.04.010"},{"key":"CIT0093","unstructured":"Anacor Pharmaceuticals Inc. Tavaborole 5% solution medical review(s). [Internet] Drugs@FDA; 2014. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/204427Orig1s000MedR.pdf."},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2014.921158"},{"key":"CIT0095","unstructured":"Anacor Pharmaceuticals Inc. Tavaborole 5% solution pharmacology review(s).[Internet] Drugs@FDA; 2014. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/204427Orig1s000PharmR.pdf."},{"issue":"11","key":"CIT0096","first-page":"34","volume":"9","author":"Elewski BE","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"CIT0097","first-page":"815","volume":"13","author":"Gupta AK","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02056-12"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2014.919852"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.07.012"},{"key":"CIT0101","unstructured":"Valeant Canada LP. Product monograph Jublia [Internet] 2017. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00040037.PDF."},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.013"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.12.3797-3801.2002"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00111-14"},{"issue":"11","key":"CIT0105","first-page":"1388","volume":"13","author":"Sakamoto M","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"CIT0106","first-page":"7","volume":"21","author":"Gupta AK","year":"2016","journal-title":"Skin Therapy Lett"},{"issue":"11","key":"CIT0107","first-page":"1394","volume":"13","author":"Elewski BE","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"CIT0108","first-page":"34","volume":"7","author":"Zeichner JA","year":"2014","journal-title":". J Clin Aesthet Dermatol"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2016.1146687"},{"issue":"9","key":"CIT0110","first-page":"1010","volume":"12","author":"Jarratt M","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"CIT0111","unstructured":"Valeant Canada. Efinaconazole 10% solution medical review(s). [Internet] Drugs@FDA; 2014. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/203567Orig1s000MedR.pdf."},{"key":"CIT0112","unstructured":"Valeant Canada. Efinaconazole 10% solution pharmacology(s). [Internet] Drugs@FDA; 2014. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/203567Orig1s000PharmR.pdf."},{"issue":"4","key":"CIT0113","first-page":"203","volume":"92","author":"Tosti A.","year":"2013","journal-title":"Cutis"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1159\/000017990"},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.3.353"},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2013.12088"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70111-7"},{"issue":"3","key":"CIT0118","first-page":"279","volume":"15","author":"Gupta AK","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12545"},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2002.00589.x"},{"key":"CIT0121","first-page":"31","author":"Gupta AK","year":"1999","journal-title":"Postgrad Med"},{"key":"CIT0122","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022010-00004"},{"key":"CIT0123","doi-asserted-by":"publisher","DOI":"10.1586\/edm.12.58"},{"key":"CIT0124","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01283.x"},{"key":"CIT0125","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1994.tb02893.x"},{"key":"CIT0126","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2012.12068"},{"key":"CIT0127","doi-asserted-by":"publisher","DOI":"10.7547\/1020309"},{"key":"CIT0128","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-010-9347-9"},{"key":"CIT0129","doi-asserted-by":"publisher","DOI":"10.1159\/000246174"},{"key":"CIT0130","doi-asserted-by":"publisher","DOI":"10.7547\/14-088"},{"key":"CIT0131","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12048"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09546634.2020.1810607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:54:39Z","timestamp":1723424079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09546634.2020.1810607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":131,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4,3]]}},"alternative-id":["10.1080\/09546634.2020.1810607"],"URL":"https:\/\/doi.org\/10.1080\/09546634.2020.1810607","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}